Labo Euromedis (FRA:61R) Total Assets: €39.49 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:61R Labo Euromedis FRA:61R
61 GF Score
Price €4.76
GF Value €4.35
! 6 Warning Signs
View Full Analysis

What is Labo Euromedis Total Assets?

Labo Euromedis FRA:61R 61 Total Assets is €39.49 Mil as of Dec. 2025. GuruFocus rates FRA:61R with a GF Score™ of 61/100 and a GF Value™ of €4.35. The stock has 6 warning signs investors should review.

Labo Euromedis's Total Assets for the quarter that ended in Dec. 2025 was €39.49 Mil.

During the past 12 months, Labo Euromedis's average Total Assets Growth Rate was -3.30% per year. During the past 3 years, the average Total Assets Growth Rate was -11.60% per year. During the past 5 years, the average Total Assets Growth Rate was -20.20% per year. During the past 10 years, the average Total Assets Growth Rate was -9.50% per year.

During the past 13 years, Labo Euromedis's highest 3-Year average Total Assets Growth Rate was 11.80%. The lowest was -29.10%. And the median was -0.80%.

Total Assets is connected with ROA %. Labo Euromedis's annualized ROA % for the quarter that ended in Dec. 2025 was -1.17%. Total Assets is also linked to Revenue through Asset Turnover. Labo Euromedis's Asset Turnover for the quarter that ended in Dec. 2025 was 0.51.

Labo Euromedis  (FRA:61R) Total Assets Explanation

Total Assets is connected with ROA %.

Labo Euromedis's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-0.462/( (39.777+39.493)/ 2 )
=-0.462/39.635
=-1.17 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Labo Euromedis's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=20.399/( (39.777+39.493)/ 2 )
=20.399/39.635
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Labo Euromedis Total Assets Related Terms

Labo Euromedis Total Assets Historical Data

* Premium members only.

The historical data trend for Labo Euromedis's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labo Euromedis Total Assets Chart

Labo Euromedis Annual Data
Trend Jul15 Jul16 Jul17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.72 59.87 46.26 38.79 39.49

Labo Euromedis Semi-Annual Data
Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.26 45.47 38.79 39.78 39.49
FRA:61R
61GF Score
Labo Euromedis FRA:61R
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Labo Euromedis Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Labo Euromedis's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=16.409+23.084
=39.49

Labo Euromedis's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=16.409+23.084
=39.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of €39.49 Mil mean?
Labo Euromedis (FRA:61R) has a Total Assets of €39.49 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Labo Euromedis and its competitors.
Is Labo Euromedis' Total Assets too high?
Labo Euromedis' current Total Assets is €39.49 Mil. Overall, Labo Euromedis has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Labo Euromedis' Total Assets compare to MCK and CAH?
Labo Euromedis' Total Assets of €39.49 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Distribution company?
A good Total Assets depends on the Medical Distribution industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Labo Euromedis and its competitors. Labo Euromedis's current Total Assets is €39.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labo Euromedis stock overvalued right now?
Labo Euromedis (FRA:61R) has a current Total Assets of €39.49 Mil. The stock's GF Value™ is €4.35, compared to a current price of €4.76 — trading 9.4% above its estimated fair value. The current Total Assets is €39.49 Mil. Labo Euromedis' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Labo Euromedis (FRA:61R), the current Total Assets is €39.49 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Labo Euromedis (FRA:61R) Overvalued in 2026?

Based on GuruFocus' analysis, Labo Euromedis stock appears to be overvalued. The current stock price of €4.76 is trading 9.4% above its estimated GF Value™ of €4.35.

Key valuation signals for FRA:61R:

  • Total Assets: €39.49 Mil
  • GF Value™: €4.35 vs. price of €4.76 (9.4% above fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the FRA:61R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Labo Euromedis Business Description

Address ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290
Labo Euromedis is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.
61GF Score

Get the complete analysis for FRA:61R

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.76
Price
€4.35
GF Value